Veritas In Silico News

Veritas In Silico: Unconsolidated financial statements for the six-month period ending June 30, 2024 [based on Japanese accounting standards]

Aug 4 23:00 ET

Veritas In Silico: Announcements of individual stocks regarding the achievement of milestones for joint drug discovery research with Takeda Pharmaceuticals sp adr.

Jun 19 03:00 ET

Veritas In Silico: Notice regarding changes in officers

Feb 19 04:00 ET

Veritas In Silico: Notice regarding a decrease in the amount of capital (capital reduction)

Feb 13 04:30 ET

Veritas In Silico: Independent Officer Notification Form

Feb 7 19:15 ET

Veritas In Silico: Articles of Incorporation 2023/08/18

Feb 7 18:12 ET

Veritas In Silico: Notice Concerning Changes in Major Shareholders

Feb 7 18:00 ET

Veritas In Silico: Matters relating to business plans and growth potential

Feb 7 18:00 ET

Veritas In Silico: Notice of our financial results information etc. associated with listing on the Tokyo Stock Exchange Growth Market

Feb 7 18:00 ET

Veritas In Silico: Confirmation of the appropriateness of securities reports, etc. for listing applications

Jan 5 03:00 ET

Veritas In Silico: Quarterly Report for Listing Applications (3rd Quarter)

Jan 5 03:00 ET

Veritas In Silico: Quarterly Report for Listing Applications (Q2)

Jan 5 03:00 ET

Veritas In Silico: Quarterly Report for Listing Applications (First Quarter)

Jan 5 03:00 ET

Veritas In Silico: securities reports for listing applications

Jan 5 03:00 ET